Mannkind (MNKD) Cash from Investing Activities Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 116.52% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.24% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -22.09% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 30.54% |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | 10.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.73% |
| Dec 31, 2025 | -177.85% |
| Sep 30, 2025 | -42.87% |
| Jun 30, 2025 | 45.72% |
| Mar 31, 2025 | 29.08% |
| Dec 31, 2024 | 80.02% |
| Sep 30, 2024 | -117.33% |
| Jun 30, 2024 | 21.14% |
| Mar 31, 2024 | -15.52% |
| Dec 31, 2023 | -20.79% |
| Sep 30, 2023 | -1,323.95% |
| Jun 30, 2023 | 197.86% |
| Mar 31, 2023 | -11.43% |
| Dec 31, 2022 | 324.15% |
| Sep 30, 2022 | 93.73% |
| Jun 30, 2022 | 51.50% |
| Mar 31, 2022 | -16.43% |
| Dec 31, 2021 | -272.18% |
| Jun 30, 2020 | -102.06% |
| Mar 31, 2020 | 6.03% |
| Mar 31, 2019 | -181.10% |
| Dec 31, 2018 | 7.87% |
| Jun 30, 2017 | 26.05% |
| Mar 31, 2017 | 139.96% |
| Mar 31, 2016 | 8.25% |
| Dec 31, 2015 | -72.30% |
| Sep 30, 2015 | -110.34% |
| Jun 30, 2015 | -277.92% |
| Mar 31, 2015 | -143.53% |
| Dec 31, 2014 | -384.46% |
| Sep 30, 2014 | 28.51% |
| Jun 30, 2014 | -26.77% |
| Mar 31, 2014 | -40.40% |
| Dec 31, 2013 | 8.74% |
| Sep 30, 2013 | -36.03% |